Purpose: We review the morbidity and long-term outcome of percutaneous caliceal diverticulectomy and associated stone extraction.
Materials And Methods: Percutaneous caliceal diverticulectomy was performed in 19 women and 11 men (age range 20 to 58 years), of whom 26 had stones (all 15 mm. or less). The diverticula were located throughout the kidney, including the upper (11 patients), middle (15) and lower (4) calices. Percutaneous caliceal diverticulectomy included 28 direct and 2 indirect accesses (1 via a previously placed nephrostomy tract and 1 due to stones in other areas of the kidney). In all cases the stone was removed and the diverticular neck was incised or dilated. Fulguration of the diverticular walls was performed in 22 cases. Transdiverticular percutaneous renal and ureteral drainage was maintained from 2 to 7 days until a nephrostogram demonstrated no extravasation.
Results: The average operating room time and hospital stay were 171 minutes (range 75 to 330) and 4.1 days (range 2 to 7), respectively. Major complications occurred in 6.6% of the cases, requiring 1 blood transfusion and 1 chest tube placement, and minor complications occurred in 13.4%. There was no mortality. Followup for more than 1 year was available in 27 patients. Stone-free rate was 93% with obliteration of the diverticulum in 76% of patients. Overall, 85% of patients are asymptomatic at average followup of 3.5 years (range 1 to 7.3).
Conclusions: Direct percutaneous endosurgical management provides a safe, efficacious and durable means of treating stone bearing caliceal diverticula, regardless of stone size or location of the diverticulum.
Download full-text PDF |
Source |
---|
BMC Urol
January 2025
Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, 710032, China.
Background: There is still controversy about the best minimally invasive surgical method for the treatment of calyceal diverticulum calculi. We conducted meta-analysis to evaluate the effectiveness and safety of PCNL and FURL in the treatment of calyceal diverticulum calculi.
Methods: We searched Pubmed, Cochrane Library, Web of Science, Embase, Clinical trial platform, CNKI, VIP until April 2024.
Urolithiasis
October 2024
Department of Urology, Kasr Alainy hospitals, Faculty of Medicine, Cairo University, Cairo, Egypt.
To assess outcomes of supracostal ultrasound guided approach percutaneous nephrolithotomy (SUGA-PNL) and retrograde intrarenal surgery (RIRS) in isolated large volume upper calyceal stones (UCS). This was a prospective randomized study including patients with isolated UCS > 20mm. The patients were randomized into two groups: group (P) (SUGA-PNL) and group (R) (RIRS).
View Article and Find Full Text PDFJ Endourol
January 2025
Department of Urology, Icahn School of Medicine at Mount Sinai, Foggia, Italy.
One advantage of supine percutaneous nephrolithotomy (sPCNL) is the ability to access anterior as well as posterior calyces, but the safety and efficacy of anterior calyceal entry has never been investigated to our knowledge. We prospectively evaluated patients scheduled for sPCNL comparing anterior and posterior calyceal access. After Institutional Review Board approval, we prospectively enrolled 100 consecutive patients undergoing sPCNL from February to September 2023.
View Article and Find Full Text PDFJ Pak Med Assoc
October 2024
Department of Urology, AL Yarmouk Teaching Hospital, Mustansiriyah University, Baghdad, Iraq.
Objective: To compare upper, middle and lower calyceal accesses for prone percutaneous nephrolithotomy regarding stone-free rates, residual stones, haemoglobin drop and fluoroscopic time.
Methods: The prospective comparative clinical study was conducted from September 2018 to March 2021 at Al- Yarmouk Teaching Hospital, Baghdad, Iraq, and comprised patients of either gender aged 18-78 years with renal stones treated with percutaneous nephrolithotomy. They were divided into three groups on the basis of calyx access: upper calyx G1, mid-calyx G2, and lower calyx G3.
J Int Med Res
August 2024
Department of Urology, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!